阵发性运动障碍
拉考沙胺
左乙拉西坦
相伴的
医学
癫痫
奥卡西平
丙戊酸
儿科
运动障碍
卡马西平
内科学
精神科
疾病
帕金森病
作者
Junhong Geng,Yang Zheng,Quanfu Li,Qun Hou,Xiao-Hang Wang,Yan Jiang
标识
DOI:10.3389/fneur.2022.826897
摘要
Background Paroxysmal kinesigenic dyskinesia (PKD) is characterized by recurrent episodes of movement-induced motor attacks. PKD patients may have concomitant epilepsy. Differentiation between the two disorders and effective control of both diseases remain challenging. Case Presentation We present a Chinese girl with typical manifestations of PKD, who also suffered from generalized tonic-clonic seizure attacks at the same time. Genetic testing confirmed a PRRT2 mutation (c.649dupC). Oxcarbazepine was initially used, but withdrawn due to a hypersensitivity reaction. Levetiracetam was initiated afterwards, which was effective for seizures but failed to control her PKD symptoms. The addition of lacosamide (LCM) completely controlled her PKD symptoms. Conclusion This is the first case reporting the effectiveness of LCM for concomitant PKD and epilepsy. Our case proposes a novel alternative for such patients who are resistant or cannot tolerate conventional anti-sodium antiepileptics.
科研通智能强力驱动
Strongly Powered by AbleSci AI